Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review
Chimeric antigen receptor (CAR) macrophage therapy represents a promising new frontier in cancer immunotherapy, with the potential to overcome the limitations of CAR-T cell approaches, particularly in solid tumours. This comprehensive review focuses on the current state and future prospects of CAR m...
Saved in:
| Main Authors: | Ahsen Morva, Ana Belén Arroyo, Liudmila Andreeva, Ana Tapia-Abellán, Ginés Luengo-Gil |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1615760/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
by: Eugenio Galli, et al.
Published: (2021-10-01) -
Study of the suppression of a tumor growth expressing a carcinoembryonic antigen with a new high-tech drug carplasmin (CAR-T therapy) in Balb/c nude mice
by: V. K. Bozhenko, et al.
Published: (2023-04-01) -
CAR-T: from bench to bedside
by: M. О. Popova, et al.
Published: (2024-09-01) -
CAR-NK cells: harnessing the power of natural killers for advanced cancer therapy
by: Filipa D. dos Reis, et al.
Published: (2025-05-01) -
Research progress on chimeric antigen receptor-based immunotherapy against autoimmune diseases
by: Mingwei Jiang, et al.
Published: (2025-12-01)